News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,506 Results
Type
Article (41532)
Company Profile (462)
Press Release (657512)
Section
Business (208365)
Career Advice (2001)
Deals (35936)
Drug Delivery (91)
Drug Development (83271)
Employer Resources (169)
FDA (16324)
Job Trends (15041)
News (352021)
Policy (32973)
Tag
Academia (2619)
Alliances (50563)
Alzheimer's disease (1262)
Approvals (16237)
Artificial intelligence (131)
Bankruptcy (361)
Best Places to Work (11683)
Biotechnology (346)
Breast cancer (113)
Cancer (996)
Career advice (1670)
Cell therapy (224)
Clinical research (65745)
Collaboration (359)
Compensation (175)
COVID-19 (2583)
C-suite (89)
Data (959)
Diabetes (143)
Diagnostics (6172)
Earnings (85693)
Employer resources (147)
Events (112537)
Executive appointments (260)
FDA (16794)
Funding (313)
Gene therapy (168)
GLP-1 (601)
Government (4404)
Healthcare (18985)
Infectious disease (2661)
Inflammatory bowel disease (108)
Interviews (308)
IPO (16550)
Job creations (3694)
Job search strategy (1427)
Layoffs (436)
Legal (7923)
Lung cancer (162)
Manufacturing (162)
Medical device (13300)
Medtech (13305)
Mergers & acquisitions (19410)
Metabolic disorders (398)
Neuroscience (1520)
NextGen Class of 2024 (6731)
Non-profit (4531)
Northern California (1321)
Obesity (236)
Opinion (195)
Patents (97)
People (57513)
Pharmaceutical (87)
Phase I (20592)
Phase II (29010)
Phase III (21480)
Pipeline (322)
Postmarket research (2590)
Preclinical (8841)
Radiopharmaceuticals (250)
Rare diseases (204)
Real estate (5996)
Regulatory (21895)
Research institute (2402)
Resumes & cover letters (351)
Southern California (1184)
Startups (3745)
United States (12651)
Vaccines (558)
Weight loss (178)
Date
Today (304)
Last 7 days (1051)
Last 30 days (3415)
Last 365 days (36791)
2024 (32081)
2023 (41013)
2022 (52276)
2021 (56765)
2020 (54924)
2019 (47419)
2018 (35697)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (731)
Arizona (196)
Asia (38429)
Australia (6385)
California (3021)
Canada (1209)
China (225)
Colorado (130)
Connecticut (140)
Europe (83783)
Florida (416)
Georgia (104)
Illinois (328)
Indiana (189)
Kansas (99)
Maryland (557)
Massachusetts (2484)
Michigan (147)
Minnesota (263)
New Jersey (881)
New York (889)
North Carolina (731)
Northern California (1321)
Ohio (131)
Pennsylvania (788)
South America (1105)
Southern California (1184)
Texas (415)
Utah (86)
Washington State (346)
699,506 Results for "evolveimmune therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics
October 31, 2024
·
5 min read
Press Releases
EvolveImmune Therapeutics to Present New Preclinical Data Highlighting Pipeline Progress for EVOLVE T Cell Engager Platform at 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 24, 2024
·
5 min read
Pharm Country
EvolveImmune Therapeutics Provides Corporate and Program Update Highlighted by Closing of $37 Million Financing
EvolveImmune Therapeutics provided a corporate and program update related to the advancement of its pipeline of first-in-category precision immuno-oncology agents.
December 13, 2023
·
4 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Business
EvolveImmune Therapeutics Enters into Strategic Research Collaboration with Kennedy Institute of Rheumatology
EvolveImmune Therapeutics, an immuno-oncology company developing first-in-category, multifunctional biotherapeutics to overcome cancer-driven immunodeficiency, announced a new research partnership with Michael Dustin, Ph.D., to evaluate the molecular mechanism of action of EvolveImmune’s proprietary costimulatory T cell engager platform, known as EVOLVE.
June 14, 2023
·
3 min read
Pharm Country
EvolveImmune Therapeutics to Present New Preclinical and Translational Data Highlighting Precision Medicine Potential of its Novel Costimulatory T Cell Engager Platform at 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
EvolveImmune Therapeutics will be presented at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), which is being held November 1-5, 2023, in San Diego, California.
October 18, 2023
·
4 min read
Drug Development
EvolveImmune Therapeutics Presents New Preclinical and Translational Data on Novel CD2 Costimulatory T Cell Engager Platform at 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
EvolveImmune Therapeutics announced that new preclinical and translational data highlighting EV-104 and EV-106, two programs utilizing EVOLVE, the company’s proprietary costimulatory T cell engager platform were presented at the 38th Annual Meeting of the Society for Immunotherapy of Cancer.
November 6, 2023
·
6 min read
Press Releases
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
October 8, 2024
·
14 min read
Business
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
Gain Therapeutics, Inc. announces that Matthias Alder has departed the Company in order to pursue other opportunities.
June 27, 2024
·
5 min read
Press Releases
ReCerise Therapeutics Inc. Selected for Government Project by MOTIE
Initiates Development of Tailored Innovative Targeted Therapy for Refractory Cancer ReCerise Therapeutics Inc., has announced its selection for a grant from the Ministry of Trade, Industry and Energy of South Korea.
July 1, 2024
·
2 min read
1 of 69,951
Next
